Werbung
Werbung

LPCN

LPCN logo

Lipocine Inc.

8.06
USD
Gesponsert
+0.53
+7.04%
09. Jan., 15:58 UTC -5
Geschlossen
exchange

Nach-Markt

8.03

-0.03
-0.37%

LPCN Ergebnisberichte

Positives Überraschungsverhältnis

LPCN übertreffen die 27 der letzten 40Schätzungen.

68%

Nächster Bericht

Datum des nächsten Berichts
11. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$118.32K
/
-$0.62
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+2.89%
/
+5.08%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-96.61%
/
-133.33%

Lipocine Inc. earnings per share and revenue

On 06. Nov. 2025, LPCN reported earnings of -0.59 USD per share (EPS) for Q3 25, missing the estimate of -0.55 USD, resulting in a -7.12% surprise. Revenue reached 115.00 tausend, compared to an expected 242.76 tausend, with a -52.63% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 118.32 tausend USD, implying an increase of 5.08% EPS, and increase of 2.89% in Revenue from the last quarter.
FAQ
For Q3 2025, Lipocine Inc. reported EPS of -$0.59, missing estimates by -7.12%, and revenue of $115.00K, -52.63% below expectations.
The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.
The next earning report is scheduled for 11. März 2026.
Based on 4 analysts, Lipocine Inc. is expected to report EPS of -$0.62 and revenue of $118.32K for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung